|
TTopical PDT - Key references: 1990-2005 (Updated: 7/05)
This bibliography includes the main publications concerning the clinical use of topical PDT in Dermatology.
*Denotes a predominantly review article.
Particular disease indications, where mentioned in the title, are noted in bold.
1990
Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: Basic principles and present clinical experience. J Photochem Photobiol B Biol 1990; 6: 143-8.
Santoro O, Banieramonte G, Melloni E, et al. Photodynamic therapy by topical meso-tetraphenylporphinesulfonate tetrasodium salt administration in superficial basal cell carcinomas. Cancer Res 1990; 50: 4501-3.
1992
*Henderson BW, Dougherty TJ. How does photodynamic therapy work? Photochem and Photobiol. 1992; 55: 145-57.
Kennedy JC and Pottier RH. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B: Biol 1992; 14: 275-92.
1993
Karrer S, Sziemies RM, Hohenleutner U, et al. Unilateral localized basaliomatosis: treatment with topical photodynamic therapy after application of 5-aminolaevulinic acid. Dermatology. 1995; 190 (3): 218-22.
*Lui H, Anderson RR. Photodynamic therapy in Dermatology; recent developments. Dermatol Clin 1993; 11: 1-13.
Wolf P, Rieger E, Kerl H. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas and basal cell carcinomas? J Am Acad Dermatol 1993; 28:17-21.
1994
Boehncke WH, Konig K, Ruck A, et al. In vitro and in vivo effect of photodynamic therapy in cutaneous T cell lymphoma. Acta Dermato-Venereologica 1994; 74: 201-5.
Boehncke WH, Konig K, Kaufmann R, et al. Photodynamic therapy in psoriasis: suppression of cytokine production in vitro and recording of fluorescence modification during treatment in vivo. Arch Dermatol Res 1994; 286: 300-3.
Boehncke W-H, Sterry W, Kaufmann R. Treatment of psoriasis by topical photodynamic therapy with polychromatic light. Lancet 1994; 343: 801.
Cairnduff F, Stringer MR, Hudson EJ, et al. Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer. Br J Cancer 1994; 69: 605-8.
Svanberg K, Anderson T, Killander D, et al. Photodynamic therapy of non-melanoma malignant tumours of the skin using topical 5-aminolaevulinic acid sensitisation and laser irradiation. Br J Dermatol 1994; 130: 743-51.
Szeimies RM, Sassy T, Landthaler M: Penetration potency of topical applied 5-aminolaevulinic acid for photodynamic therapy of basal cell carcinoma. Photochem Photobiol 1994, 59: 73-76.
Warloe T, Heyerdahl H, Peng Q, Giercksky K-E. Photodynamic therapy with 5-aminolaevulinic acid induced porphyrins and skin penetration enhancer for basal cell carcinoma. SPIE, 1994; 2371:226-235.
Weinstein GD, McCullough JL, Jeffes EW, et al. Photodynamic therapy (PDT) of psoriasis with topical delta aminolevulinic acid (ALA): a pilot dose-ranging study. Photochem Photobiol Photoimmunol 1994; 10: 92.
Wolf P, Fink-Punches R, Cerroni L, Kerl H. Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolaevulinic acid. J Am Acad Dermatol 1994; 31: 678-80.
1995
Ammann R, Hunziker T, Braathen LR. Topical photodynamic therapy in verrucae. A pilot study. Dermatology 1995; 191: 346-7.
Ammann R, Hunziker R. Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolaevulinic acid. J Am Acad Dermatol 1995; 33: 541.
Calzavara-Pinton PG. Repetitive photodynamic therapy with topical 5-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. J Photochem Photobiol B: Biol 1995; 29: 53-57.
Fijan S, Honigsmann H, Ortel B. Photodynamic therapy of epithelial skin tumours using delta-aminolaevulinic acid and desferrioxamine. Br J Dermatol 1995; 133:282-8.
Grossman M, Wimberly J, Dwyer P et al. PDT for hirsutism. Lasers Surg Med 1995; 7 (suppl): 44.
Gudgin Dickson EF, Pottier RH. On the role of protoporphyrin IX photoproducts in photodynamic therapy. J. Photochem Photobiol B: Biol. 1995; 29: 91-3.
Heinritz H. Benzel W. Sroka R. Iro H. Photodynamic therapy of superficial skin tumors following local application of delta-aminolaevulinic acid. Advances in Oto-Rhino-Laryngology. 1995; 49:48-52.
Lang S. Baumgartner R. Struck R. Leunig A. Gutmann R. Feyh J. Photodynamic diagnosis and therapy of neoplasms of the facial skin after topical administration of 5-aminolevulinic acid. [German] Laryngo- Rhino- Otologie. 1995; 74: 85-9.
Lui H, Salasche S, Kollias N et al. Photodynamic therapy of non-melanoma skin cancer with topical aminolaevulinic acid: A clinical and histologic study. Arch Dermatol 1995; 131: 737-738.
Martin A, Tope WD, Grevelink JM, et al. Lack of selectivity of protoporphyrin IX flourescence for basal cell carcinoma after topical application of 5-aminolevulinic acid: implications for photodynamic treatment. Arch Dermatol Res 1995; 287: 665-74.
Morton CA, Whitehurst C, Moseley H, et al. Development of an alternative light source to lasers for photodynamic therapy: Clinical evaluation in the treatment of pre-malignant non-melanoma skin cancer. Lasers Med Sci. 1995; 10: 165-71.
Orenstein A, Kostenick G, Taur H, et al. Temperature monitoring during photodynamic therapy of skin tumours with topical 5-aminolaevulinic acid application. Cancer Letters 1995; 93: 227-32.
Peng Q, Warloe T, Moan J, et al. Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma. Photochem and Photobiol 1995; 62(5): 906-13.
*Roberts DJH and Cairnduff F. Photodynamic therapy of primary skin cancer: a review. Br. J. of Plast Surg 1995; 48: 360-70.
1996
Fiedler DM, Eckl PM, Krammer B. Does d-aminolaevulinic acid induce genotoxic effects? J Photochem Photobiol B Biol 1996; 33: 39-44.
Frank RG, Bos JD, Meulen FW, Sterenborg HJ. Photodynamic therapy for condylomata acuminata with local application of 5-aminolaevulinic acid. Genitourin Med 1996; 72: 70-1.
Morton CA, Whitehurst C, Moseley H, et al. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br J Dermatol. 1996; 135: 766-71.
Orenstein A, Kostenich G, Roitman L, et al. Photodynamic therapy of malignant lesions of the skin mediated by topical application of 5-aminolevulinic acid in combination with DMSO and EDTA. Lasers in Life Sciences 1996; 7: 1-9.
Oseroff AR, Whitaker J, Conti C, et al. Effects of fluence and intensity in PDT of cutaneous T-cell lymphoma with topical ALA: high intensities spare the epidermis. J Invest Dermatol 1996; 106:950.
Stender IM, Wulf HC. Photodynamic therapy with 5-aminolaevulinic acid in the treatment of actinic cheilitis. Br J Dermatol 1996; 135: 454-456.
Stender IM, Wulf HC. Kobner reaction induced by photodynamic therapy using delta-aminoleavulinic acid. Acta Derm Venereol.(Nor.) 1996; 76/5: 392-3.
Stender IM, Wulf HC. Treatment of recalcitrant verrucae by photosensitivity with topical application of -aminolaevulinic acid. Clin Exp Dermatol 1996; 21: 390.
Stringer MR, Collins P, Robinson DJ, et al. The accumulation of protoporphyrin IX in plaque psoriasis after topical application of 5-aminolaevulinic acid indicates a potential for superficial photodynamic therapy. J Invest Dermatol 1996; 107: 76-81.
Szeimes RM, Karrer S, Sauerwald A, Landthaler M. Photodynamic therapy with topical application of 5-aminolaevulinic acid in the treatment of actinic keratoses: an initial clinical study. Dermatology 1996; 192: 246-251.
Wennberg A, Lindholm L, Alpsten M et al. Treatment of basal cell carcinomas using topically applied delta-aminolaevulinic acid and a filtered xenon lamp. Arch Dermatol Res 1996; 288: 561-4.
1997
Collins P, Robinson DJ, Stringer MR, et al. The variable response of plaque psoriasis after a single treatment with topical 5 aminolaevulinic acid photodynamic therapy. Br J Dermatol 1997; 137: 743-749.
Fink-Puches R, Hofer A, Smolle J, et al. Primary clinical response and long-term follow-up of solar keratoses treated with topically applied 5-aminolaevulinic acid and irradiation by different wave bands of light. 1997; J Photochem Photobiol B: Biol 1997; 41: 145-151.
Fritsch C, Stege H, Saalmann G, et al. Green light is effective and less painful than red light in photodynamic therapy of facial solar keratoses. Photoderm Photoimmunol Photomed 1997; 13: 181-5.
Jeffes EW, McCullough JL, Weinstein GD, et al. Photodynamic therapy of actinic keratoses with topical 5-aminolaevulinic acid. Arch Dermatol 1997; 133: 727-32.
Orenstein A. Kostenich G. Malik Z. The kinetics of protoporphyrin fluorescence during ALA-PDT in human malignant skin tumors. Cancer Letters. 1997; 120(2):229-34.
*Peng Q., Warloe T, Berg K, et al. 5-ALA based photodynamic therapy. Cancer 1997; 79 (12): 2282-308.
Rhodes LE, Tsoukas MM, Anderson RR, Kollias N. Iontophoretic delivery of ALA provides a quantitative model for ALA pharmacokinetics and PpIX phototoxicity in human skin. J Invest Derm 1997; 108: 87-91.
Stables GI, Stringer MR, Robinson DV, Ash DV. Large patches of Bowen’s disease treated by topical aminolaevulinic acid photodynamic therapy. Br J. Dermatol 1997; 136: 957-60.
Stables GI, Stringer MR, Robinson DJ. The treatment of cutaneous T-cell lymphoma by topical aminolaevulinic acid photodynamic therapy. Br J Dermatol 1997; 137(Suppl. 50): 50.
Stender IM, Bech-Thomsen N, Poulsen T, Wulf HC. Photodynamic therapy with topical delta-aminolevulinic acid delays UV photocarcinogenesis in hairless mice. Photochem Photobiol 1997; 66: 493-496.
Wang I, Anderson-Ellis S, Nilsson GE, et al. Superficial blood flow following photodynamic therapy of malignant non-melanoma skin tumours measured by laser doppler perfusion imaging. Br. J. Dermatol. 1997; 136: 184-89.
Wolf P, Fink-Puches R, Reimann-Weber A, Kerl H. Development of malignant melanoma after repeated topical photodynamic therapy with 5-aminolevulinic acid at the exposed site. Dermatology 1997; 194: 53-54.
1998
Edstrom DW, Ros AM, Parvit A. Topical 5-aminolaevulinic acid based photodynamic therapy for mycosis fungoides - A study of cell proliferation and apoptosis before and after therapy. J Dermatol Sci. 1998; 16 (1001),: 229.
Fink-Puches R, Soyer HP, Hofer A, et al. Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy. Arch Dermatol 1998; 134; 821–6.
*Fritsch C, Goerz G, Ruzicka T. Photodynamic therapy in dermatology. Arch. Dermatol. 1998; 134: 207-14.
*Fritsch C. Lang K. Neuse W. Ruzicka T. Lehmann P. Photodynamic diagnosis and therapy in dermatology. Skin Pharmacology & Applied Skin Physiology. 1998; 11: 358-73.
Harth Y, Hirschowitz B, Kaplan B. Modified topical photodynamic therapy of superficial skin tumors, utilizing aminolevulinic acid, penetration enhancers, red light and hyperthermia. Dermatol Surg 1998; 24(7): 723-6.
Hurlimann AF. Photodynamic therapy of superficial basal cell carcinomas using topical 5-aminolevulinic acid in a nanocolloid lotion. Dermatology 1998; 197: 248-54.
Martin-Hirsch PL, Whitehurst C, Moseley H, et al. Photodynamic therapy for lower genital tract intra-epithelial neoplasia. Lancet 1998; 351: 1403.
Morton CA, MacKie RM, Whitehurst C, et al. Photodynamic therapy for basal cell carcinoma: effect of tumor thickness and duration of photosensitizer application on response. Arch Dermatol 1998; 134: 248-9.
1999
*Cox NH, Eady DJ, Morton CA. Guidelines for the management of Bowen’s disease. Br J. Dermatol 1999; 141: 633-41.
Dierickx CC, Goldenhersh M, Dwyer P, et al. Photodynamic therapy for nevus sebaceus with topical -aminolaevulinic acid. Arch Dermatol 1999; 135: 637-40.
*Fritsch C, Lang K, Neuse W et al., Photodynamic diagnosis and therapy in dermatology. Skin Pharmacol Appl Skin Physiol 1998; 11: 358-73.
Gupta G, Morton CA, Whitehurst C, et al. Photodynamic therapy with meso-tetra(hydroxyphenyl)chlorin in the topical treatment of Bowen's disease and basal cell carcinoma. Br. J. Dermatol. 1999; 141: 385-6.
Henta T, Itoh Y, Kobayashi M, et al. Photodynamic therapy for inoperable vulval Paget’s disease using -aminolaevulinic acid: successful management of a large skin lesion. Br J Dermatol 1999; 141: 347-349.
Hillemanns P, Untch M, Prove F, et al. Photodynamic therapy of vulvar lichen sclerosus with 5-aminolaevulinic acid. Obstetrics and Gynecology 1999; 93: 71-4.
Karrer S, Baumler W, Abels C, et al. Long-pulse dye laser for photodynamic therapy. Lasers in Surg & Med. 1999: 25(1); 51-9.
Karrer S, Szeimies R-M, Abels C, et al. Epidermodysplasia verruciformis treated using topical 5-aminolaevulinic acid photodynamic therapy. Br J Dermatol 1999; 140: 935-938.
Kirby B, Whitehurst C, Moore JV, Yates VM. Treatment of lichen planus of the penis with photodynamic therapy. Br J Dermatol 1999; 141: 747-776.
Kurwa HA, Yong-Gee SA, Seed PT, et al. A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses. J Am Acad Dermatol 1999; 41: 414-8.
Robinson DJ. de Bruijn HS. van der Veen N. Stringer MR. Brown SB. Star WM. Protoporphyrin IX fluorescence photobleaching during ALA-mediated photodynamic therapy of UVB-induced tumors in hairless mouse skin. Photochemistry & Photobiology. 1999; 69: 61-70.
Robinson DJ, Collins P, Stringer MR, et al. Improved response of plaque psoriasis after multiple treatment with topical 5-aminolaevulinic acid photodynamic therapy. Acta Derm Venereol 1999; 79: 451-455.
Soler AM, Warloe T, Tausjo J, Berner A. Photodynamic therapy by topical aminolaevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: a one year follow-up study. Acta Derm Venereol 1999: 79(3); 204-6.
Stables GI, Stringer MR, Robinson DJ, Ash DV. Erythroplasia of Queyrat treated by topical aminolaevulinic acid photodynamic therapy. Br J Dermatol 1999; 140: 514-7.
Stender IM, Lock-Anderson J, Wulf HC. Recalcitrant hand and foot warts successfully treated with photodynamic therapy with topical 5-aminolaevulinic acid: a pilot study. Clin Exp Dermatol 1999; 24: 154-159.
Stender IM, Wulf HC. Photodynamic therapy of recalcitrant warts with 5-aminolaevulinic acid: A retrospective analysis. Acta Dermato-Venereol 1999: 79: 400.
Telfer NR, Colver GB, Bowers PW. Guidelines for the management of basal cell carcinoma. Br J Dermatol. 1999; 141: 415-23.
Wang I, Bauer B, Andersson-Engels S, et al. Photodynamic therapy utilising topical delta-aminolaevulinic acid in non-melanoma skin malignancies of the eyelid and the periocular skin. Acta Ophthalmologica Scandinavica 1999; 77: 182-8.
2000
Ackermann G. Abels C. Karrer S. Baumler W. Landthaler M. Szeimies RM. Fluorescence-assisted biopsy of basal cell carcinomas. Hautarzt. 2000: 51(12):920-4.
van den Akker JT. de Bruijn HS. Beijersbergen van Henegouwen GM. Star WM. Sterenborg HJ. Protoporphyrin IX fluorescence kinetics and localization after topical application of ALA pentyl ester and ALA on hairless mouse skin with UVB-induced early skin cancer. Photochemistry & Photobiology. 2000; 72(3):399-406.
Basset-Seguin N., Bachmann I., Pavel S, et al. A dose-finding study of photodynamic therapy (PDT) with Metvix in patients with basal cell carcinoma (BCC). J Eur Acad Dermatol Venereol 2000 14 (Suppl 1), 39.
Bissonnette R, Shapiro J, Zeng H, et al. Topical photodynamic therapy with 5 aminolaevulinic acid does not induce regrowth in patients with extensive alopecia. Br J Dermatol 2000; 143: 1032-1035.
Braathen, L., Paredes, B., Frölich, K, et al. A dose-finding study of photodynamic therapy (PDT) with Metvix in actinic keratoses. J Eur Acad Dermatol Venereol 2000; 14 (Suppl 1), 38.
*Ceburkov O, Gollnick H. Photodynamic therapy in dermatology. Eur J Dermatol 2000; 10: 568-76.
Fuchs J, Weber S, Kaufmann R. Genotoxic potential of porphyrin type photosensitizers with particular emphasis on 5-aminolevulinic acid: implications for clinical photodynamic therapy. Free Rad Biol Med 2000; 28: 537-548.
Gerscher S, Connelly JP, Griffiths J, et al. Comparison of the pharmacokinetics and phototoxicity of protoporphyrin IX metabolized from 5-aminolevulinic acid and two derivatives in human skin in vivo. Photochem and Photobiol 2000; 72(4): 569-74.
Guillen C, Sanmartin O, Escudero A, Botella-Estrada R, Svila A, Castejon P. Photodynamic therapy for in situ squamous cell carcinoma on chronic radiation dermatitis after photosensitization with 5-aminolevulinic acid. J Eur Acad Dermatol 2000; 14: 298-300.
Haller JC, Cairnduff F, Slack G, et al. Routine double treatments of superficial basal cell carcinomas using aminolaevulinic acid-based photodynamic therapy. Br J Dermatol. 2000; 143: 1270-74.
Hillemans P, Untch M, Danneker C et al. Photodynamic therapy of vulval intra-epithelial neoplasia using 5-aminolaevulinic acid. Int J Cancer 2000; 85: 649-53.
Hongcharu W, Taylor CR, Chang Y, et al. Topical ALA-Photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol 2000; 115: 183-192.
Itoh Y, Ninomiya Y, Tajima S, Ishibashi A. Photodynamic therapy for acne vulgaris with topical 5-aminolaevulinic acid. Arch Dermatol 2000; 136: 1093-95.
Itoh Y, Ninomiya T, Henta T et al. Topical 5-aminolaevulinic acid-based photodynamic therapy for Japanese actinic keratoses. J of Dermatol 2000; 27: 513-518.
*Kalka K, Merk H, Mukhtar H. Photodynamic therapy in dermatology. J Am Acad Dermatol 2000; 42: 389-413.
Karrer S, Abels C, Landthaler M, Szeimies R-M. Topical photodynamic therapy for localized scleroderma. Acta Dermato-Venereol 2000; 80: 26-27.
Kurwa HA, Barlow RJ, Neill S. Single-episode photodynamic therapy and vulval intraepithelial neoplasia type III resistant to conventional therapy. Br J Dermatol 2000; 143: 1040-1042.
Morton CA, Whitehurst C, Moore JV, MacKie RM. Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy. Br J Dermatol 2000; 143: 767-772.
Orenstein A, Haik J, Tamir J, et al. Photodynamic therapy of cutaneous lymphoma using 5-aminolaevulinic acid topical application. Dermatol Surg 2000; 26: 765-70.
*Ormrod D, Jarvis B. Topical aminolaevulinic acid HCL photodynamic therapy. Am J Clin Dermatol 2000 1 (2): 133-139.
Rud E, Gederaas O, Hogset A, Berg K. 5-aminolaevulinic acid, but not 5-aminolaevulinic acid esters, is transported into adenocarcinoma cells by system BETA transporters. Photochem Photobiol 2000; 71(5): 640-7.
Salim A, Morton CA. Comparison of photodynamic therapy with topical 5-fluorouracil in Bowen’s disease. Br J Dermatol 2000;114 (Suppl. 57):114.
Soler AM, Angell-Petersen E, Warloe T, et al. Photodynamic therapy of superficial basal cell carcinoma with 5-aminolaevulinic acid with dimethylsulphoxide and ethyendiaminetetraacetic acid: a comparison of two light sources. Photochem Photobiol 2000; 71 (6): 724-9.
Stefanidou M. Tosca A. Themelis G. Vazgiouraki E. Balas C. In vivo fluorescence kinetics and photodynamic therapy efficacy of delta-aminolevulinic acid-induced porphyrins in basal cell carcinomas and actinic keratoses; implications for optimization of photodynamic therapy. European Journal of Dermatology. 2000; 10:351-6.
Stender IM, Na R, Fogh H, et al. Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trail. Lancet 2000; 355: 963-66.
Szeimies, R. M., Radakovic, S., Calzavara-Pinton, P. G, et al. A prospective, randomized study comparing photodynamic therapy with Metvix, to cryotherapy in actinic keratoses J Eur Acad Dermatol Venereol, 2000; 14 (Suppl 1): 235.
Thissen MR, Schroeter CA, Neumann HA. Photodynamic therapy with delta-aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique. Br J Dermatol Feb 2000; 142(2): 338-9.
Varma S, Holt PJA, Anstey AV. Erythroplasia of Queyrat treated by topical aminolaevulinic acid photodynamic therapy: a cautionary tale . Br J Dermatol 2000; 142; 825-6.
Zollo JD, Zeitouni NC. The Roswell Park Cancer Institute experience with extramammary Paget’s disease. Br J Dermatol 2000; 142: 59-65.
2001
Basset-Sequin N, Ibbotson S, Emtestam L, et al. Photodynamic therapy using Metvix is as efficacious as cryotherapy in basal cell carcinoma, with better cosmetic results. J Eur Acad Dermatol Venereol, 2001; 15 (Suppl 2): 226.
Bissonnette R. Zeng H. McLean DI. Korbelik M. Lui H. Oral aminolevulinic acid induces protoporphyrin IX fluorescence in psoriatic plaques and peripheral blood cells. Photochemistry & Photobiology. 2001; 74(2):339-45.
de Blois AW. Thissen MR. de Bruijn HS. Grouls RJ. Dutrieux RP. Robinson DJ. Neumann HA. In vivo pharmacokinetics of protoporphyrin IX accumulation following intracutaneous injection of 5-aminolevulinic acid. Journal of Photochemistry & Photobiology. B - Biology. 2001; 61: 21-9.
Buchczyk DP. Klotz LO. Lang K. Fritsch C. Sies H. High efficiency of 5-aminolevulinate-photodynamic treatment using UVA irradiation. Carcinogenesis. 2001; 22(6):879-83.
Casas A. Perotti C. Fukuda H. Rogers L. Butler AR. Batlle A. ALA and ALA hexyl ester-induced porphyrin synthesis in chemically induced skin tumours: the role of different vehicles on improving photosensitization. Br. J Cancer. 2001; 85(11):1794-800.
Finlay JC. Conover DL. Hull EL. Foster TH. Porphyrin bleaching and PDT-induced spectral changes are irradiance dependent in ALA-sensitized normal rat skin in vivo. Photochemistry & Photobiology. 2001; 73(1):54-63.
Fischer F. Dickson EF. Kennedy JC. Pottier RH. An affordable, portable fluorescence imaging device for skin lesion detection using a dual wavelength approach for image contrast enhancement and aminolaevulinic acid-induced protoporphyrin IX. Part II. In vivo testing. Lasers in Med Sci. 2001; 16(3):207-12.
Foley P, Freeman M, Vinciullo C, et al. A comparison of photodynamic therapy using Metvix with cryotherapy in actinic keratosis. J Eur Acad Dermatol Venereol, 2001; 15 (Suppl 2): 223.
Gerscher S., Connelly J.P., Beijersbergen van Henegouwen G.M.J., et al. A quantitative assessment of protoporphyrin IX metabolism and phototoxicity in human skin following dose-controlled delivery of the prodrugs 5-aminolaevulinic acid and 5-aminolaevulinic acid-n-pentylester. Br J Dermatol 2001; 144: 983-990.
Hewett J. Nadeau V. Ferguson J. Moseley H. Ibbotson S. Allen JW. Sibbett W. Padgett M. The application of a compact multispectral imaging system with integrated excitation source to in vivo monitoring of fluorescence during topical photodynamic therapy of superficial skin cancers. Photochemistry & Photobiology. 2001; 73(3):278-82.
Itoh Y, Ninomiya Y, Tajima S, Ishibashi A. Photodynamic therapy of acne vulgaris with topical 5-aminolaevulinic acid and incoherent light in Japanese patients. Br J Dermatol 2001; 144: 575-79.
Jayasree RS. Gupta AK. Rathinam K. Mohanan PV. Mohanty M. The influence of photodynamic therapy on the wound healing process in rats. J Biomaterials Applications. 2001; 15(3):176-86.
Langmack K, Mehta R, Twyman P, Norris P. Topical photodynamic therapy at low fluence rates - theory and practice. J Photochem Photobiol B: Biol 2001; 60: 37-43.
Leman JA, Morton CA, MacKie RM Treatment of superficial basal cell carcinomas with topical photodynamic therapy; recurrence rates and outcome. Br J Dermatol. 2001; 145: (Suppl.59) 17.
Markham T, Sheahan K, Collins P. Topical 5-aminolaevulinic acid photodynamic therapy for tumour stage mycosis fungoides. Br J Dermatol 2001; 144: 1262-3.
Markham T, Collins P. Topical 5-aminolaevulinic acid photodynamic therapy for extensive actinic keratoses. Br J Dermatol 2001; 145: 502-504.
Mehta RK, Levell NJ, Langmack K, Norris PG. Low intensity light photodynamic therapy (PDT) using a novel 635nm light source is effective in Bowen's disease. Br J Dermatol. 2001; 145 (suppl.59): 54-5.
*Morton CA. Treating basal cell carcinoma: has photodynamic therapy come of age?. Br J of Dermatol. 2001; 145:1-2.
* Morton CA. Topical photodynamic therapy in dermatology. South African Medical Journal. 2001; 91(8):634-7.
Morton CA, Burden AD. Treatment of multiple scalp basal cell carcinomas by photodynamic therapy. Clin Exp Derm 2001; 26: 33-36.
Morton CA, Whitehurst C, McColl JH, et al. Photodynamic therapy for large or multiple patches of Bowen's disease and basal cell carcinoma Arch Dermatol. 2001; 137: 319-324.
Musser DA. Oseroff AR. Characteristics of the immunosuppression induced by cutaneous photodynamic therapy: persistence, antigen specificity and cell type involved. Photochemistry & Photobiology. 2001; 73(5):518-24.
Peng Q. Soler AM. Warloe T. Nesland JM. Giercksky KE. Selective distribution of porphyrins in thick basal cell carcinoma after topical application of methyl 5-aminolevulinate. Journal of Photochemistry & Photobiology. B - Biology. 2001; 62 (3):140-5.
Sharfaei S. Viau G. Lui H. Bouffard D. Bissonnette R. Systemic photodynamic therapy with aminolaevulinic acid delays the appearance of ultraviolet-induced skin tumours in mice. Br J of Dermatol. 2001; 144: 1207-14.
Soler AM, Warloe T, Berner A, Giercksky KE. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated by methyl 5-aminolaevulinate-based photodynamic therapy along with prior curettage. Br J Dermatol. 2001; 145: 467-71.
Varma S, Wilson H, Kurwa HA, et al. Bowen's disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source. Br J. Dermatol 2001; 144: 567-74.
Wang I, Bendsoe N, Klinteberg CAF, et al. Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial. Br J Dermatol. 2001; 144: 832-40.
Wong TW. Sheu HM. Lee JY. Fletcher RJ. Photodynamic therapy for Bowen's disease (squamous cell carcinoma in situ) of the digit. Dermatologic Surgery. 2001; 27:452-6.
Zeina B. Greenman J. Purcell WM. Das B. Killing of cutaneous microbial species by photodynamic therapy. Br J Dermatol. 2001; 144(2):274-8.
Zeitouni NC. Shieh S. Oseroff AR. Laser and photodynamic therapy in the management of cutaneous malignancies Clinics in Dermatology. 2001; 19:328-38.
2002
*Braathen LR. Photodynamic therapy: when and why? J Eur Acad Dermato Venereol 2002; 16: 227.
Escudero A, Nagore E, Sevilla A, et al. Chronic X-ray dermatitis treated by topical 5-aminolaevulinic acid photodynamic therapy. Br J of Dermatol. 2002; 147: 394-5.
* Ibbotson SH. Topical 5-aminolaevulinic acid photodynamic therapy for the treatment of skin conditions other than non-melanoma skin cancer. Br J of Dermatol. 2002; 146 :178-88.
Karrer S, Abels C, Wimmershoff MB, Landthaler M, Szeimies RM. Successful treatment of cutaneous sarcoidosis using topical photodynamic therapy. Arch Dermatol. 2002; 138: 581-584.
*Leman JA, Morton CA. Photodynamic therapy: applications in dermatology. Expert Opin Biol Ther. 2002; 2 (1):45-53.
Leman JA, Dick DC, Morton CA. Topical 5-ALA photodynamic therapy for the treatment of cutaneous T-cell lymphoma. Clin and Exptl Dermatol. 2002; 27: 516-8.
Lieb S. Szeimies RM. Lee G. Self-adhesive thin films for topical delivery of 5-aminolevulinic acid. European Journal of Pharmaceutics & Biopharmaceutics. 2002; 53(1):99-106.
*Morton CA, Brown SB, Collins C, et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 2002, 146, 552-567.
*Morton CA. The emerging role of 5-ALA-PDT in dermatology: is PDT superior to standard treatments? J Dermatolog Treat. 2002;13 Suppl 1:S25-9. Review
*Morton CA. Realizing the cometic potential of photodynamic therapy. J of Cos Dermatol. 2002; 1:66-71.
Rodriguez R. Photodynamic photorejuvenation. Dermatol Surg, 2002, 28(8).742-744.
Ruiz-Rodriguez R, Alvarez JG, Jaén P, Acevedo A & Córdoba S. Photodynamic therapy with 5-aminolevulinic acid for recalcitrant familial benign pemphigus (Hailey-Hailey disease J Am Acad Dermatol 2002, 45, 740-742.
Szeimies RM, Karrer S, Radakovic-Fijan S, et al. Photodynamic therapy using topical methyl-5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. J Am Acad Dermatol. 2002; 47:258-62.
Thissen MR. de Blois MW. Robinson DJ. et al. PpIX fluorescence kinetics and increased skin damage after intracutaneous injection of 5-aminolevulinic acid and repeated illumination. J Investig Dermatol. 2002; 118(2):239-45.
2003
Alexiades-Armenakas MR, Geronemus RG. Laser-mediated photodynamic therapy of actinic keratoses. Arch Dermatol 2003; 139: 1313-1320.
Alster TS. Tanzi EL. Photodynamic therapy with topical aminolevulinic acid and pulsed dye laser irradiation for sebaceous hyperplasia Journal of Drugs in Dermatology: 2003 2(5):501-4.
Babilas P. Schacht V. Liebsch G. Wolfbeis OS. Landthaler M. Szeimies RM. Abels C. Effects of light fractionation and different fluence rates on photodynamic therapy with 5-aminolaevulinic acid in vivo. Br J of Cancer. 2003; 88(9):1462-9.
*Bäumler W, Abels C, Szeimies RM. Fluorescence diagnosis and photodynamic therapy in dermatology. Med Laser Appl 2003; 18: 47-56.
Blecha-Thalhammer U, Hönigsmann H & Tanew A. Comparison of incoherent versus pulsed monochromatic light for photodynamic therapy of actinic keratoses. JEADV 2003 17 (Suppl.3), 102-164.
*Brown SB. The role of light in the treatment of non-melanoma skin cancer using methyl aminolevulinate. Journal of Dermatological Treatment. 2003, 14 Suppl 3:11-4.
Campbell S, Leman JA, Curnow A, Morton CA, Salter L and Gould D. Enhancing dermatological 5-aminolaevulinic acid photodynamic therapy with a novel iron chelator. Br J Dermatol 2003; 149 (suppl 64): 92.
Chamberlain AJ. Kurwa HA. Photodynamic therapy: is it a valuable treatment option for actinic keratoses Am J Clin Dermatol. 2003; 4(3):149-55.
Choudry K, Brooke RCC, Farrar W and Rhodes LE. The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy. Br J Dermatol 2003; 149: 124-130.
Clark C. Bryden A. Dawe R. Moseley H. Ferguson J. Ibbotson SH. Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources Photodermatology, Photoimmunology & Photomedicine. 2003, 19(3):134-41.
Enk CD. Fritsch C. Jonas F. Nasereddin A. Ingber A. Jaffe CL. Ruzicka T. Treatment of cutaneous leishmaniasis with photodynamic therapy. Arch Dermatol. 2003; 139(4):432-4.
Ericson MB. Grapengiesser S. Gudmundson F. Wennberg AM. Larko O. Moan J. Rosen A. A spectroscopic study of the photobleaching of protoporphyrin IX in solution. Lasers in Medical Science. 2003; 18(1):56-62.
Exadaktylou D, Kurwa HA, Calonje E,Barlow RJ. Treatment of Darier's disease with photodynamic therapy. Br J Dermatol 2003, 149, 606-610.
*Foley P. Clinical efficacy of methyl aminolevulinate (Metvix) photodynamic therapy. Journal of Dermatological Treatment. 2003, 14 Suppl 3:15-22.
Freeman M. Vinciullo C. Francis D. et al. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatol Treatment. 2003; 14(2):99-106.
Gardlo K. Horska Z. Enk CD. Rauch L. Megahed M. Ruzicka T. Fritsch C. Treatment of cutaneous leishmaniasis by photodynamic therapy. J Am Acad Dermatol 2003;. 48(6):893-6.
Gold MH. Intense pulsed light therapy for photorejuvination enhanced with 20% aminolevulinic acid photodynamic therapy. JEADV 2003 17 (Suppl.3), 102-164.
Gollnick SO. Evans SS. Baumann H. Owczarczak B. Maier P. Vaughan L. Wang WC. Unger E. Henderson BW. Role of cytokines in photodynamic therapy-induced local and systemic inflammation. Br J of Cancer. 2003; 88(11):1772-9.
Horio T, Horio O, Miyauchi-Hashimoto H, Ohnuki M, Isei T. Photodynamic therapy of sebaceous hyperplasia with topical 5-aminolaevulinic acid and slide projector. British Journal of Dermatology, 2003, 148, 1270-1290.
Horn M, Wolf P, Wulf HC, et al. Topical methyl aminolevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. British Journal of Dermatology 2003; 149 (6): 1242-9.
Itagaki T. Doi M. Sato S. Kato S. Skin burn caused by operating light during a long operation after photodynamic therapy. Anesthesiology. 2003; 98(4):1011-3.
Karrer S. Bosserhoff AK. Weiderer P. Landthaler M. Szeimies RM. Influence of 5-aminolevulinic acid and red light on collagen metabolism of human dermal fibroblasts. Journal of Investigative Dermatology. 2003; 120(2):325-31.
*Kendall CA. Morton CA. Photodynamic therapy for the treatment of skin disease. Technology in Cancer Research & Treatment. 2003 2(4):283-8.
Leman JA, Morton CA. Topical photodynamic therapy for basal cell carcinoma - optimizing response. Br. J Dermatol. 2003; 149 (suppl64):47.
*Morton CA. Methyl aminolevulinate (Metvix) photodynamic therapy - practical pearls. Journal of Dermatological Treatment. 2003, 14 Suppl 3:23-6.
Mizuki D, Kaneko T, Hanada K. Successful treatment of topical photodynamic therapy using 5-aminolevulinic acid for plane warts. Br J Dermatol. 2003 149, 1087-1088.
Moiin A. Photodynamic therapy for molluscum contagiosum infection in HIV-coinfected patients: review of 6 patients. Journal of Drugs in Dermatology: 2003, 2(6):637-9.
Moore JV, Allan E. Pulsed ultrasound measurements of depth and regression of basal cell carcinomas after photodynamic therapy: relationship to probability of 1 year local control. Br J Dermatol. 2003; 149 (5): 1035-40.
Nakaseko H. Kobayashi M. Akita Y. Tamada Y. Matsumoto Y. Histological changes and involvement of apoptosis after photodynamic therapy for actinic keratoses. Br J Dermatol. 2003; 148(1):122-7.
Pålsson S, Gustafsson L, Bendsoe N, Soto Thompson M, Andersson-engels S & Svanberg K. Kinetics of the superficial perfusion and temperature in connection with photodynamic therapy of basal cell carcinomas using esterified and non-esterified 5-aminolaevulinic acid. British Journal of Dermatology 2003: 148: 1179-1188.
Pariser DM, Lowe NJ, Stewart DM, et al. Photodynamic therapy with topical methyl aminolevulinate for actinic keratoses: results of a prospective randomized multicenter trial. J Am Acad Dermatol. 2003; 48:227-232.
Robinson DJ. de Bruijn HS. Star WM. Sterenborg HJ. Dose and timing of the first light fraction in two-fold illumination schemes for topical ALA-mediated photodynamic therapy of hairless mouse skin. Photochemistry & Photobiology. 2003; 77(3):319-23.
Salim A, Leman JA, McColl JH, et al. Randomized comparison trial of photodynamic therapy with topical 5-fluorouracil in Bowen's disease. Br J Dermatol 2003, 148, 539-543.
Smith S. Piacquadio D. Morhenn V. Atkin D. Fitzpatrick R. Short incubation PDT versus 5-FU in treating actinic keratoses. Journal of Drugs in Dermatology: 2003. 2(6):629-35.
*Stapleton M. Rhodes LE. Photosensitizers for photodynamic therapy of cutaneous disease. Journal of Dermatological Treatment. 2003; 14:107-12.
Stefanaki IM, Georgiou S, Themelis GC, Vazgiouraki EM & Tosca AD. In vivo fluorescence kinetics and photodynamic therapy in condylomata acuminata. British Journal of Dermatology 2003; 149: 972-976.
Touma DJ. Gilchrest BA. Topical photodynamic therapy: a new tool in cosmetic dermatology. Seminars in Cutaneous Medicine & Surgery. 2003, 22(2):124-30.
Wiegell SR, Stender I-M, Na R, Wulf HC. Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin. Arch Dermatol 2003, 139, 1173-1177.
Yang CH, Lee JC, Chen CH, et al. Photodynamic therapy for bowenoid papulosis using a novel incoherent light-emitting diode device. Br J of Dermatol 2003; 149 (6): 1297-8.
Zeina B. Greenman J. Corry D. Purcell WM.Antimicrobial photodynamic therapy assessment of genotoxic effects on keratinocytes in vitro. Br J of Dermatol. 2003; 148:229-32.
*Zeitouni NC. Oseroff AR. Shieh S. Photodynamic therapy for nonmelanoma skin cancers. Current review and update. Molecular Immunology. 2003, 39(17-18):1133-6.
2004
Alexiades-Armenakas M. Laser-mediated photodynamic therapy of lichen sclerosus. Journal of Drugs in Dermatology:2004. 3 (Suppl):S25-7.
Alexiades-Armenakas MR. Geronemus RG. Laser-mediated photodynamic therapy of actinic cheilitis. Journal of Drugs in Dermatology 2004, 3(5):548-51
Ahmadi S. McCarron PA. Donnelly RF. Woolfson AD. McKenna K. Evaluation of the penetration of 5-aminolevulinic acid through basal cell carcinoma: a pilot study. Experimental Dermatology. 2004, 13(7):445-51.
Avram DK. Goldman MP. Effectiveness and safety of ALA-IPL in treating actinic keratoses and photodamage. Journal of Drugs in Dermatology:2004. 3 (Suppl):S36-9.
Basset-Seguin N, Ibbotson S, Emtestam L, Tarstedt M, Morton C, Maroti M,
Calzavara-Pinton P, Varma S, Roelandts R, Wolf P, Saksela O, Rosdahl I. MAL-PDT vs. cryotherapy in primary sBCC: results of 36 months follow-up. JEADV 2004; 18 (Suppl 2): 412.
Beattie PE, Dawe RS, Ferguson J & Ibbotson SH. Lack of efficacy and tolerability of topical PDT for psoriasis in comparison with narrowband UVB phototherapy. Clinical and Experimental Dermatology. 2004, 29, 545-562.
Bissonette R, Bergeron A, Liu T. Large surface photodynamic therapy with aminolevulinic acid: treatment of actinic keratoses and beyond. Drugs Dermatol 2004:3:S26-S31.
Calzavara-Pinton PG, Venturini M, Capezzera R, Sala R, Zane C. Photodynamic therapy of interdigital mycoses of the feet with topical application of 5-aminolevulinic acid. Photodermal Photoimmunol Photomed 2004; 20: 144 –7
Cappugi P. Mavilia L. Campolmi P. Reali EF. Mori M. Rossi R. New proposal for the treatment of nodular basal cell carcinoma with intralesional 5-aminolevulinic acid. Journal of Chemotherapy. 2004, 16(5):491-3.
Clark C. Dawe RS. Moseley H. Ferguson J. Ibbotson SH. The characteristics of erythema induced by topical 5-aminolaevulinic acid photodynamic therapy. Photodermatology, Photoimmunology & Photomedicine. 2004, 20(2):105-7.
Coors EA, von den Driesch P. Topical photodynamic therapy for patients with therapy-resistant lesions of cutaneous T-cell lymphoma. . J Am Acad Dermatol. 2004; 50:3, 363-7.
Dover JS, Bhatia A, Stewart B, Arndt K. A bilateral comparison of the efficacy and safety of photodynamic therapy with 20% aminolevulinic acid (ALA) topical solution and intense pulsed light alone in the treatment of mild to moderate photoaging. J Am Acad Dermatol. 2004, 50 (3), 625.
Dragieva G, Hafner J, Dummer R, Schmid-Grendelmeier P, Roos M, Prinz BM, et al. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen’s disease in transplant recipients. Transplantation 2004; 77: 115-121
Dragieva G. Prinz BM. Hafner J. Dummer R. Burg G. Binswanger U. Kempf W. A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients. British Journal of Dermatology. 2004, 151(1):196-200.
Ericson MB. Sandberg C. Stenquist B. Gudmundson F. Karlsson M. Ros AM. Rosen A. Larko O. Wennberg AM. Rosdahl I. Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome. British Journal of Dermatology. 2004, 151(6):1204-12.
Holmes MV, Dawe RS, Ferguson J & Ibbotson SH. A randomised, double-blind, placebo-controlled study of the efficacy of tetracaine gel (Ametop®) for pain relief during topical photodynamic therapy. British Journal of Dermatology 2004: 150: 337-340.
Gold MH. A single center, open label split face investigator study of photodynamic therapy in the treatment of photoaging with topical 20% 5-aminolevulinic acid and intense pulsed light. J Am Acad Dermatol. 2004, 50 (3), 641.
Gold MH, Bridges NM, Bradshaw VL, Boring M. ALA-PDT and blue light therapy for hidradenitis suppurativa. Drugs Dermatol 2004; 3:S32-S39.
Gold MH. Boring MM. Bridges TM. Bradshaw VL. The successful use of ALA-PDT in the treatment of recalcitrant molluscum contagiosum Journal of Drugs in Dermatology: 2004, 3(2):187-90.
Gold MH. Goldman MP. 5-aminolevulinic acid photodynamic therapy: where we have been and where we are going. Dermatologic Surgery. 2004, 30(8):1077-83; discussion 1083-4.
Gold MH. Bradshaw VL. Boring MM. Bridges TM. Biron JA. Lewis TL. Treatment of sebaceous gland hyperplasia by photodynamic therapy with 5-aminolevulinic acid and a blue light source or intense pulsed light source. Journal of Drugs in Dermatology: 2004, 3(6 Suppl):S6-9.
Gupta AK. Single-blind, randomised, controlled trial to evaluate the efficacy and safety of photodynamic therapy using aminolevulinic acid versus liquid nitrogen cryotherapy in the management of verrucae plantaris. J Am Acad Dermatol. 2004, 50 (2), 427.
Gupta AK. Single-blind, randomised controlled trial to evaluate the efficacy and safety of photodynamic therapy using aminolevulinic acid versus 5-flurouracil in the management of actinic keratosis. J Am Acad Dermatol. 2004, 50 (2), 501.
Itkin A. Gilchrest BA. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome Dermatologic Surgery. 2004, 30(7):1054-61.
Karrer, S., Bosserhoff, A.K., Weiderer, P., Landthaler, M. & Szeimies, R.-M.
Keratinocyte-derived cytokines after photodynamic therapy and their paracrine induction of matrix metalloproteinases in fibroblasts. British Journal of Dermatology 2004 151(4),776-783.
Kuijpers DIM, Smeets NWJ, Krekels GAM, Thissen MRTM. Photodynamic therapy as adjuvant treatment of extensive basal cell carcinoma treated with Mohs micrographic surgery. Dermatol Surg 2004; 30: 794-798.
Kimura M. Itoh Y. Tokuoka Y. Kawashima N. Delta-aminolevulinic acid-based photodynamic therapy for acne on the body. Journal of Dermatology. 2004. 31(12):956-60.
Lui H, Hobbs L, Tope WD, Lee PK, Elmets C, Provost N, Chan A, Neyndorff H, Su XY, Jain H, Hamzavi I, McLean D, Bissonnette R. Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light-emitting diodes. Two-year results evaluating tumour response and cosmetic outcomes. Arch Dermatol.2004:140:26-32.
Maisch T. Szeimies RM. Jori G. Abels C. Antibacterial photodynamic therapy in dermatology. Photochemical & Photobiological Sciences.2004, 3(10):907-17.
Morton CA. Photodynamic Therapy for nonmelanoma skin cancer - and more? Arch Dermatol 2004; 140: 116-120.
Morton CA, Campbell S, Gould D, Curnow A. Topical photodynamic therapy with the iron chelator, CP94, for nodular basal cell carcinoma. J Am Acad Dermatol. 2004, 50 (2), 463.
Morton C, Horn M, Leman J, Tack B, Bédane C, Tjioe M, Ibbotson S, Khemis D, Wolf P. A placebo controlled European study comparing MAL-PDT with cryotherapy and 5-fluoracil in patients with Bowen’s disease. JEADV 2004; 18 (Suppl 2): 415.
Oakford M & Keohane SG. Photodynamic therapy to manage residual superficial basal cell carcinomas following Mohs’ surgery. DS-12. British Journal of Dermatology 2004, 151 (Suppl.68), 91-102.
Pagliaro J, Elliott T, Bulsara M, King C, Vinciullo C. Cold air analgesia in photodynamic therapy of basal cell carcinomas and Bowen’s disease: an effective addition to treatment: a pilot study. Dermatol Surg 2004; 30: 63-66.
Parlette EC. Red light laser photodynamic therapy of Bowen's disease. Journal of Drugs in Dermatology: 2004. 3(6 Suppl):S22-4.
Piacquadio DJ, Chen DM, Farber HF, Fowler Jr JF, Glazer SD, Goodman JJ, Hruza KK, Jeffes EWB, Ling MR, Phillips TJ, Rallis TM, Scher RK, Taylor CR, Weinstein GD. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp. Investigator-blinded, Phase 3, Multicenter trials. Arch Dermatol. 2004; 140:41-46.
Pollock B. Turner D. Stringer MR. Bojar RA. Goulden V. Stables GI. Cunliffe WJ. Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action. British Journal of Dermatology. 2004, 151(3):616-22.
Rhodes LE, de Rie M, Enström Y, Groves R, Morken R, Goulden V, Wong GAE, Grob J-J, Varma S, Wolf P. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma. Results of a multicenter randomized prospective trial. Arch Dermatol 2004, 140, 17-23.
Sheleg SV, Zhavrid EA, Khodina TV, Kochubeev GA, Istomin YP, Chalov VN, Zhuravkin Photodynamic therapy with chlorin e(6) for skin metastases of melanoma. Photodermatol Photoimmunol Photomed 2004; 20: 21-26.
*Siddiqui MA. Perry CM. Scott LJ. Topical methyl aminolevulinate. American Journal of Clinical Dermatology. 2004, 5(2):127-37; discussion 138-40.
Tan B. Sinclair R. Foley P. Photodynamic therapy for subungual Bowen's disease. Australasian Journal of Dermatology. 2004, 45(3):172-4.
*Taub AF. Photodynamic therapy in dermatology: history and horizons. Drugs Dermatol 2004; 3: S8-S25.
Taub AF. Photodynamic therapy for the treatment of acne: a pilot study. Journal of Drugs in Dermatology 2004. 3(6 Suppl):S10-4.
Tope WD, Menter A, El-Azhary RA, Lowe NJ. Comparison of topical methylaminolevulinate photodynamic therapy versus placebo photodynamic therapy in nodular basal cell carcinoma. J Am Acad Dermatol. 2004, , 50 (2), 477.
Touma D, Yaar M, Whitehead S, Konnikov N, Gilchrest BA. A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage. Arch Dermatol 2004; 140: 33-40.
Wang, X.L., Wang, H.W., Wang, H.S., Xu, S.Z., Liao, K.H. & Hillemanns, P. Topical 5-aminolaevulinic acid-photodynamic therapy for the treatment of urethral condylomata acuminata. British Journal of Dermatology 2004, 151(4), 880-885.
Weston A. Fitzgerald P. Discrete choice experiment to derive willingness to pay for methyl aminolevulinate photodynamic therapy versus simple excision surgery in basal cell carcinoma. Pharmacoeconomics. 2004, 22(18):1195-208.
Wulf HC, Philipsen P. Allergic contact dermatitis to 5-aminolaevulinic acid methylester but not 5-aminolaevulinic acid after photodynamic therapy. Br J Dermatol 2004; 150: 143-145
Zawislak AA. McCarron PA. McCluggage WG. Price JH. Donnelly RF. McClelland HR. Dobbs SP. Woolfson AD. Successful photodynamic therapy of vulval Paget's disease using a novel patch-based delivery system containing 5-aminolevulinic acid. BJOG. 2004, 111(10):1143-5.
2005
Alster TS. Tanzi EL. Welsh EC. Photorejuvenation of facial skin with topical 20% 5-aminolevulinic acid and intense pulsed light treatment: a split-face comparison study. Journal of Drugs in Dermatology: 2005, 4(1):35-8.
Brookes PT. Jhawar S. Hinton CP. Murdoch S. Usman T. Bowen's disease of the nipple-a new method of treatment. Breast. 2005, 14(1):65-7, 2005.
Calzavara-Pinton PG. Venturini M. Sala R. A comprehensive overview of photodynamic therapy in the treatment of superficial fungal infections of the skin. Journal of Photochemistry & Photobiology. B - Biology. 2005, 78(1):1-6, 2005.
Fukuda H. Casas A. Batlle A. Aminolevulinic acid: from its unique biological function to its star role in photodynamic therapy. International Journal of Biochemistry & Cell Biology. 2005, 37(2):272-6.
Gilbert DJ. Treatment of actinic keratoses with sequential combination of 5-fluorouracil and photodynamic therapy. Journal of Drugs in Dermatology: 2005, 4(2):161-3.
*Hamzavi I. Lui H. Using light in dermatology: an update on lasers, ultraviolet phototherapy, and photodynamic therapy. Dermatologic Clinics. 2005, 23(2):199-207.
Lee MR, Ryman W. Erythroplasia of Queyrat treated with topical methyl aminolevulinate photodynamic therapy. 2005 Australas J Dermatol 2005; 46 (3): 196-8.
Mikasa K. Watanabe D. Kondo C. Kobayashi M. Nakaseko H. Yokoo K. Tamada Y. Matsumoto Y. 5-Aminolevulinic acid-based photodynamic therapy for the treatment of two patients with extramammary Paget's disease 2005, 32(2):97-101.
Oseroff AR. Shieh S. Frawley NP. Cheney R. Blumenson LE. Pivnick EK. Bellnier DA. Treatment of diffuse basal cell carcinomas and basaloid follicular hamartomas in nevoid basal cell carcinoma syndrome by wide-area 5-aminolevulinic acid photodynamic therapy. Archives of Dermatology. 2005, 141(1):60-7.
Radakovic-Fijan S. Blecha-Thalhammer U. Schleyer V. Szeimies RM. Zwingers T. Honigsmann H. Tanew A. Topical aminolaevulinic acid-based photodynamic therapy as a treatment option for psoriasis? Results of a randomized, observer-blinded study. British Journal of Dermatology. 2005, 152(2):279-83.
Schmook T. Budde K. Ulrich C. Neumayer HH. Fritsche L. Stockfleth E. Successful treatment of nephrogenic fibrosing dermopathy in a kidney transplant recipient with photodynamic therapy. Nephrology Dialysis Transplantation.2005, 20(1):220-2.
Schroeter CA. Pleunis J. van Nispen tot Pannerden C. Reineke T. Neumann HA. Photodynamic therapy: new treatment for therapy-resistant plantar warts. Dermatologic Surgery. 2005, 31(1):71-5, 2005.
Vinciullo, C., Elliott, T., Francis, D., Gebauer, K., Spelman, L., Nguyen, R., Weightman, W., Sheridan, A., Reid, C., Czarnecki, D. & Murrell, D. Photodynamic therapy with topical methyl aminolaevulinate for 'difficult-to-treat' basal cell carcinoma. British Journal of Dermatology 2005, 152(4), 765-772.
Zelickson B. Counters J. Coles C. Selim M. Light patch: preliminary report of a novel form of blue light delivery for the treatment of actinic keratosis. Dermatologic Surgery. 2005, 31(3):375-8.
Reference Book:
Photodynamic therapy and fluorescence diagnosis in Dermatology. Calzavara-Pinton P-G, Sziemies RM, Ortel B, eds. 1st edn, Comprehensive Series in Photosciences - Vol 2. Amsterdam: Elsevier. 2001.
Meeting Abstracts:
Euro-PDT 2004 Annual Meeting, Stirling: Journal of Dermatological Treatment. 2004; 15: 256-69.
Euro-PDT 2005 Annual Meeting, Sirmione: Photodermatology, Photoimmunology & Photomedicine 2005; 21 (4): 212-223.
|
